The West Virginia Clinical and Translational Science Institute (WVCTSI) will establish a new key component area (Technology and Resources for Core Laboratories) that supports research infrastructure critical for translating basic research to practices that improve the health of West Virginians. Importantly, the Technology Core leverages previous IDeA investment in West Virginia, while bringing exciting innovation to support clinical and translational (C/T) investigators' efforts to solve meaningful problems. The Core is unique in its technology- based focus, but absolutely connected to the overarching aims of the WVCTSI that coalesce on improving health. Resources described in this Core are essential in providing infrastructure to engage and train C/T scientists about the value and availability of primary samples that define the gold standard in biologically-relevant disease models. In addition, we will develop contemporary approaches to data management of ?omics? based information that inform our understanding of disease processes. Further, expanding models to include pre- clinical imaging will elevate C/T investigations to a level not previously attainable. Each focused effort will involve training, mentoring, and technical support that result in hands-on facilitation of investigations while maintaining strict quality control, and administrative and scientific oversight. Critically, this technology-grounded core will provide products and resources that are clinically applicable and translatable.
The specific aims that will achieve our goals are to: 1) establish a statewide biospecimen repository that collects patient and study participant samples in WVCTSI priority health areas (addiction and resultant emerging epidemics (e.g., hepatitis C), cancer, cardiovascular disease, and chronic lung disease), 2) establish a statewide West Virginia University (WVU) - Marshall University (MU) genomics shared research facility for the efficient generation of genomic and related data for C/T studies that address WVCTSI priority health areas, 3) establish a statewide WVU-MU shared Bioinformatics and Data Management (BDM) Facility for C/T studies that address WVCTSI priority health areas, and 4) establish state-of-the-art imaging in support of biologically relevant modeling of disease. Focus across the Core is provided by tethering all activities to WVCTSI priority health areas to avoid diffusion of investment and energy, and maximize investment to achieve significant and measurable outcomes. Relevance is obtained by absolute diligence in the design and focus of each aim connecting to a clinical application. In combination, this results in impact on our understanding of specific diseases of interest, and the potential to impact positively on the health of West Virginians.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54GM104942-05
Application #
10004069
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
West Virginia University
Department
Type
DUNS #
191510239
City
Morgantown
State
WV
Country
United States
Zip Code
26506
Mattes, Malcolm D; Small Jr, William; Vapiwala, Neha (2018) Out of the Basement and Into the Classroom: Pathways for Expanding the Role of Radiation Oncologists in Medical Student Education. J Am Coll Radiol 15:1620-1623
Wallace, Kimberly; Zhao, Xiaohui; Misra, Ranjita et al. (2018) The Humanistic and Economic Burden Associated with Anxiety and Depression among Adults with Comorbid Diabetes and Hypertension. J Diabetes Res 2018:4842520
Khan, Safi U; Singh, Maninder; Lone, Ahmad N et al. (2018) Meta-analysis of long-term outcomes of percutaneous coronary intervention versus medical therapy in stable coronary artery disease. Eur J Prev Cardiol :2047487318800511
Dietz, Matthew J (2018) CORR Insights®: The John N. Insall Award: Higher Tissue Concentrations of Vancomycin Achieved With Intraosseous Regional Prophylaxis in Revision TKA: A Randomized Controlled Trial. Clin Orthop Relat Res 476:75-76
Winstanley, Erin L; Zhang, Yifan; Mashni, Rebecca et al. (2018) Mandatory review of a prescription drug monitoring program and impact on opioid and benzodiazepine dispensing. Drug Alcohol Depend 188:169-174
Sanzhaeva, Urikhan; Xu, Xuan; Guggilapu, Priyaankadevi et al. (2018) Imaging of Enzyme Activity by Electron Paramagnetic Resonance: Concept and Experiment Using a Paramagnetic Substrate of Alkaline Phosphatase. Angew Chem Int Ed Engl 57:11701-11705
Wright, Zachary A; Lazzaro, Emily; Thielbar, Kelly O et al. (2018) Robot Training With Vector Fields Based on Stroke Survivors' Individual Movement Statistics. IEEE Trans Neural Syst Rehabil Eng 26:307-323
Thornton, J Douglas; Dwibedi, Nilanjana; Scott, Virginia et al. (2018) Predictors of Transitioning to Incident Chronic Opioid Therapy Among Working-Age Adults in the United States. Am Health Drug Benefits 11:12-21
Fugett 2nd, James; Phillips, Lynette; Tobin, Emily et al. (2018) Selective bladder denervation for overactive bladder (OAB) syndrome: From concept to healing outcomes using the ovine model. Neurourol Urodyn 37:2097-2105
Penm, Jonathan; MacKinnon, Neil J; Mashni, Rebecca et al. (2018) Statewide cross-sectional survey of emergency departments' adoption and implementation of the Ohio opioid prescribing guidelines and opioid prescribing practices. BMJ Open 8:e020477

Showing the most recent 10 out of 998 publications